Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.26
+6.36%
Mkt Cap $737.75M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+369.3%
Consensus $5.89 vs current $1.26
NASDAQ·Healthcare·Biotechnology
$1.26
+6.36%
Mkt Cap $737.75M
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+369.3%
Consensus $5.89 vs current $1.26